). MEASUREMENTS: DNA analysis was carried out using SSCP technique, sequencing and polymerase chain reaction (PCR) followed by digestion with the restriction enzyme RsaI. Serum leptin, glucose, insulin and lipid concentrations were determined in obese subjects. RESULTS: We were able to detect a pentanucleotide insertion (CTTTA) in the 3 H -untranslated region of the leptin receptor gene. The presence of this pentanucleotide insert generates a putative stem-loop structure in the mRNA. Association studies were carried out on this variant. The frequency of the insertion allele did not differ between 249 obese (12.4%) and 138 lean (12.0%) subjects. There was no association of serum leptin, glucose or lipid levels with the pentanucleotide genotype in the obese individuals. However, when subjects without medication affecting insulin or glucose levels were considered, serum insulin levels were found to be lower in the heterozygous carriers of the insertion allele (15.1 AE 9.2 mUal) than in the subjects homozygous for the deletion allele (21.8 AE 13.7 mUal, P 0.0035). CONCLUSIONS: We were able to con®rm the presence of a frequent insertionadeletion polymorphism close to the 3 Hend of the leptin receptor gene. We also showed that serum insulin levels in morbidly obese subjects are associated with 3 H -UTR variant genotype.
Introduction
Leptin is an adipose tissue-secreted hormone postulated to regulate energy intake, body adiposity and reproductive competence. 1, 2 Its actions are mediated by various isoforms of leptin receptor, 3 that are expressed in a variety of tissues including the brain, ovaries and hematopoietic stem cells. 4 Mutations of the genes encoding leptin or leptin receptor are found in several obese strains of laboratory animals. 1,3,5±8 Recently, a single-nucleotide deletion of the leptin gene was identi®ed as a cause of severe early-onset obesity in two cousins. 9 The leptin receptor is a member of the class 1 cytokine receptor family. It has several alternatively spliced variants, of which the longest isoform Ob-Rb, 7 is thought to mediate the hypothalamic weight-regulatory actions of leptin. The functional domains in common with other cytokine receptors include the ligand binding serine residue domains and the transmembrane domain, as well as the intracellular domain containing sites for JAK and STAT interaction. 5, 10 As most obese patients have elevated leptin levels, 11±14 leptin resistance due to a genetic defect of the leptin receptor remains an attractive explanation for some forms of human obesity. Until now, four amino acid variants of the coding region, four silent mutations, nine intronic variants as well as a 3
Huntranslated region (3 H -UTR) pentanucleotide insertionadeletion polymorphism have been described in the human leptin receptor gene. 15±20 We report the results of the screening of the leptin receptor gene in Finnish morbidly obese subjects and an association of serum insulin levels with the 3 H -UTR pentanucleotide polymorphism genotype.
Methods

Subjects
We examined 249 obese subjects (70 male, 179 female) that were originally referred to The Internal Medicine outpatient ward of the Helsinki University Central Hospital, for a weight reduction program, during the years 1989 ±1995. A detailed description of their demographic and clinical characteristics is provided in our previous paper. 21 The initial admission criteria to the program were a body mass index (BMI) ! 40 kgam 2 and age between 18 ± 60 y (mean age 46 AE 9 y). Their mean (s.d.) BMI at the initial admission was 45.4 AE 5.6 kgam 2 . At the time of the present study, the mean BMI was 42.8 AE 7.1, with a range of 27±81 kgam 2 . Fifty-nine subjects had type II diabetes and 114 were treated for hypertension. Blood samples were collected for serum leptin, insulin, glucose and lipid measurements as well as DNA isolation following a 12 h fast. In addition, each subject completed a structured questionnaire including details on general medical history and medication, as well as history of weight development (birth weight, weight at age 20 y, and maximal body weight). Most of the subjects also participated in a 16-week weight reduction treatment program including a very-low calorie diet (VLCD) regimen, in the years 1989±1995. Blood samples were also collected from 138 apparently healthy lean controls (58 male, 80 female) all having BMI 25 kgam 2 (mean 22.6 AE 1.8 kgam 2 ). Their mean age was 40 AE 11 y. The protocol of this study was approved by the Ethical Review Committee of the Department of Medicine and written, informed consent was obtained from every subject.
Mutation screening by single strand conformation polymorphism
For mutation screening, 30 subjects with the highest serum leptin levels were chosen from an initial group of 249 morbidly obese adults. DNA was prepared from EDTA-anticoagulated venous blood samples using standard techniques. The PCR primers used to amplify all 18 exons were always designed according to the intronic sequences 22¯a nking the individual exons. In the case of exons 2, 4, 7, 9, 13, 14 and 18, large exon size necessitated the use of two to six overlapping PCR products.
Analysis of single strand conformation polymorphism (SSCP) was conducted essentially as described by Orita et al, 23 using 5% non-denaturing polyacrylamide sequencing gels containing 10% glycerol in 90 mM Tris-borate pH 8.3, 4 mM EDTA buffer. After electrophoresis at room temperature, the gel was transferred to a ®lter paper, dried in a vacuum slab dryer and subjected to autoradiography for 1±3 d at 770 C.
DNA sequencing
PCR templates were puri®ed using the QIAquick PCR puri®cation kits (Qiagen, Chatsworth, CA C, 55 C and 72 C were used. After PCR, aliquots (10 ml) of the samples were digested with the restriction enzyme RsaI (1 U per sample) overnight at 37 C, followed by electrophoresis on a 10% polyacrylamide gel and visualization of the cleavage products by ethidium bromide staining.
Assays for serum leptin, insulin, glucose and lipids
Serum leptin levels of the morbidly obese subjects, measured by radioimmunoassay, 11 were reported in our previous study and shown to correlate to BMI. 25 Serum glucose levels were measured by a glucose dehydrogenase technique using a commercial kit from Merck (Darmstadt, Germany). 26 Serum insulin levels were measured by a double antibody radioimmunoassay (Phadeseph Insulin RIA, Pharmacia, Uppsala, Sweden). 27 This assay shows a cross reactivity of 41% for proinsulin, but`0.1% for C-peptide, IGF-1 and IGF-2. Serum concentrations of total cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides (TG) were measured using enzymatic techniques with reagents purchased from Boehringer Mannheim (Mannheim, Germany).
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Statistical analysis
Allele frequencies were determined by gene counting. Equality of the means of the quantitative traits in the different genotypes were tested using analysis of variance. Possible association of the categorical variables with the leptin receptor gene 3
H -UTR genotypes were tested using Cochran's w 2 -test for trend. While the polymorphisms present in exons 2, 4, 12 and 18, in intron 7 as well as in intron 17, have been identi®ed previously, 15±19 there was no previous report on the silent mutation in exon 13 or the 3 H -UTR insertion polymorphism, when our studies were carried out. A PCR assay was set up for large-scale screening of the pentanucleotide polymorphism. Digestion of the 119-bp insertion allele PCR product with RsaI yields fragments of 90 and 29 bp in size, while the PCR product of the more common deletion allele remains uncleaved (Figure 2 ). Except by unequivocal RsaI digestion products, the heterozygous subjects were ef®ciently recognized by appearance of an extra band ( Figure 2 ) that probably results from generation of heteroduplexes, by annealing two heterologous (common and variant) DNA strands. A total of 249 morbidly obese subjects and 138 lean controls were genotyped for the presence of the insertionadeletion (insadel) polymorphism. The genotypes were found to be in Hardy-Weinberg equilibrium. The frequencies of the insertion allele did not differ between obese (0.124) or lean (0.120) subjects. Four obese, but none of the lean subjects, were homozygous for the insertion allele (Table 1) . Considering the morbidly obese individuals, we did not see signi®cant genotype-related phenotypic differences in characteristics such as previous, current or maximal BMI, occurrence of non-insulin dependent diabetes mellitus (NIDDM) or hypertension (Table 2) , or response (weight loss in kg) to a 16-week program, employing both a VLCD protocol, dietary and exercise counseling and behavioural modi®cations (data not shown). When mean serum insulin, glucose and lipid values were computed by genotype, serum total cholesterol levels showed a statistically signi®cant association to genotype (P 0.029; Table 2 ) that does not, however, remain signi®cant after correction for multiple comparisons.
Serum leptin levels were then compared according to the different insadel genotypes. Because serum leptin levels appear to show gender differences not totally explainable by the degree of adiposity, 32 the two genders were considered separately. The mean BMI-adjusted serum leptin values in females were 47.3 AE 19.0 ngaml in the deladel genotype (n 121), 44.2 AE 19.0 ngaml in the delains genotype (n 39) and 47.3 AE 19.2 ngaml in the insains genotype (n 3; P 0.82). In males, the corresponding mean values were 22.2 AE 13.4 ngaml (deladel, n 54), 27.8 AE 13.6 ngaml (delains, n 10) and 25.0 ngaml (insains, n 1; P 0.70).
When subjects (n 120) who were not using any medication (beta-blocking agents, thiazide diuretics, oral hypoglycaemic agents or insulin) possibly affecting serum lipid, insulin or glucose levels were considered separately (Table 3) , serum insulin levels were found to be lower in the homozygous (16.9 mUal, n 1) and heterozygous (15.1AE 9.2 mUal, n 30) carriers of the insertion allele, than in those individuals homozygous for the common (deletion) allele (21.8 AE 13.7 mUal, n 89; t-test for insadel vs deladel genotypes; P 0.0035). This difference was even more signi®cant when all diabetics, with fasting serum glucose levels b 6.5 mmolal, were excluded from the analysis. In the remaining 84 individuals, the mean serum insulin levels in the delains group (n 22) and the deladel group (n 62) were 12.3 AE 6.6 and 20.6AE 15.0 mUal, respectively (P 0.0008). As insulin-to-glucose ratio has been introduced as a simple index of insulin resistance, 33 we also calculated this ratio (in mUal per mmolal, mean AE s.d.) in the different genotypes (Table 3) . The mean insulin-to-glucose ratio in the single individual homozygous for the insertion allele was 2.3, while the same index in the 30 obese subjects with the 
Discussion
The gene coding for the leptin receptor appears a plausible candidate gene for human obesity, as genetic disruptions of the leptin receptor gene have been found in at least three animal forms of inherited obesity, 5, 6, 8 and human obesity has been almost invariably found to be associated with elevated levels of circulating leptin. 11±14 Attempts to identify alterations in the human leptin receptor gene have so 
H -UTR pentanucleotide insadel polymorphism. 15±20 Although none of these variants has been de®nitely shown to be associated with BMI levels, studies in Pima Indians showed that a cluster of one silent polymorphism and two intronic variants at the 3 H end of the receptor gene, were associated with the obese phenotype itself, suggesting that a putative mutation in obese Pima Indians could lie in the 3 H end of the gene. 16 These ®ndings prompted us to pay particular attention to the 3 H -end pentanucleotide polymorphism.
Presence of the 3 H -UTR pentanucleotide insertion does not appear to imply an increased risk for morbid obesity in Finns. Although subjects homozygous for the CTTTA insertion were exclusively found among the obese group (Table 1) , these particular individuals (n 4) did not show clinical or biochemical phenotypic characteristics markedly different from obese people with other genotypes (Table 2) . Subtle genotype-related trends were noted in serum cholesterol levels in the obese group. When subjects with medication known to affect serum glucose, insulin or lipid levels were excluded, insulin levels were found to be lower in the carriers of the insertion allele (P 0.0035) ( Table 3) . When serum insulin-toglucose ratios were similarly analyzed, carriers of the insertion allele had lower values (P 0.001), suggesting a lesser degree of insulin resistance. After completion of our studies and during preparation of this research report, a paper published by Francke et al 20 appeared, reporting the existence of the 3 H -UTR polymorphism. Interestingly, in that study, a slight trend towards lower insulin values 30 min after an oral glucose load was noticed in heterozygous carriers of the insertion allele, compared to those homozygous for the deletion allele. 20 Although the latter data are in accord with our results, more detailed studies addressing the possible relation between leptin receptor mRNA variation and insulin secretion, are required to exclude a chance association. In fact, the long form of the leptin receptor gene is expressed in pancreatic beta-cell, 34 where it is proposed to mediate leptin-induced inhibition of insulin secretion. 35, 36 This mechanism has been suggested to explain the occurrence of hyperinsulinaemia in obaob and dbadb mice. 35 Furthermore, linkage between the acute insulin response and the microsatellite marker D1S198
anking the leptin receptor gene, has also been reported in Pima Indians. 37 Several studies thus favour the idea that the leptin receptor may play a role in regulation of insulin secretion.
A number of sequence determinants are known to affect mammalian mRNA abundance. 38 Occurrence of multiple copies of the core sequence UUAUUUA(UaA)(UaA), designated as the A Udestabilizing element (AUDE), is known to destabilize a variety of mRNA species. 39 A closely reminiscent sequence of 5 H -UUACUUUAUA-3 H is created in the 3 H -UTR of the insertion allele; whether the extra C present in this sequence eliminates the destabilizing effect of the core sequence, is currently not known. It is, potentially, of greater importance that a motif compatible with stem-loop formation, with eight complementary nucleotides forming the stem and ten nucleotides the loop, is generated in the 3 H -UTR of the pentanucleotide insertion-containing mRNA molecule ( Figure 3 ). Stem-loop sequences have been detected in a number of transcripts, including mRNAs for histones, transferrin receptor, insulinlike growth factor II and cytokines. 38, 39 Although the mechanisms by which stem-loops affect mRNA stability is not completely understood, in many cases these motifs have been shown to bind to regulatory proteins, which in turn could affect the rate of degradation andaor translation of mRNA. 38 Taken together, it is tempting to speculate that the presence of the CTTTA insertion in the variant leptin receptor allele creates determinants altering the stability of the 
Conclusion
We have con®rmed the presence of a common CTTTA-pentanucleotide insertionadeletion polymorphism at the 3 H -end of the human leptin receptor gene, only 60 nucleotides downstream of the translation termination codon. Its presence generates an A Urich sequence, that should be able to form a stem-loop structure, both characteristics that may affect mRNA stability and thereby mRNA abundance in the cell. As its occurrence was associated with serum insulin levels in obesity, more detailed studies on the effects of this delains polymorphism on pancreatic insulin secretion seem to be warranted.
